KFII 10-K & 10-Q changes, risk factors and insider trading
K&f Growth Acquisition Corp. Ii (also KFIIR, KFIIU) · Nasdaq · Blank Checks · CIK 2029976 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Comparison not available: Not available: fewer than two 10-K filings on EDGAR to compare (only one so far)..
What changed in the latest 10-Q
Risk Factors
As a smaller reporting company under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in this Report. However, for detailed descriptions of the risks relating to our Company, see the section titled “Risk Factors” contained in our (i) IPO Registration Statement, (ii) 2025 Annual Report and (iii) 2025 First Quarter Form 10-Q, 2025 Second Quarter Form 10-Q and 2026 First Quarter Form 10-Q. As of the date of this Report, there have been no material changes with respect to those risk factors. Any of these previously disclosed risk factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risks not presently known to us or that we currently deem immaterial may also affect our ability to consummate an initial Business Combination. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.
Removed heading “We anticipate that our securities will be suspended from trading on Nasdaq and delisted if we do not consummate our initial Business Combination by February 4, 2028. Any trading suspension or delisting could have a material adverse effect on the trading of our securities and may adversely affect our ability to consummate an initial Business Combination.”
Removed heading “Certain agreements related to the Initial Public Offering may be amended, or their provisions waived, without shareholder approval.”
Largest changes
“We anticipate that our securities will be suspended from trading on Nasdaq and delisted if we do not consummate our initial Business Combination by February 4, 2028. Any trading suspension or delisting could have a material adverse effect on the trading of our securities and may adversely affect our ability to consummate an initial Business Combination.”see in full comparison
“In addition, if our securities are delisted from Nasdaq, trading in our securities, and offers and sales of our securities by us, may be subject to state securities regulation and additional compliance costs.”see in full comparison
“Under the Nasdaq Rules, a SPAC’s Nasdaq-listed securities will be immediately suspended from trading if the SPAC does not meet the Nasdaq 36-Month Requirement, and Nasdaq will, at such point, commence delisting procedures. Although a SPAC can request a hearing before the hearing panel of Nasdaq (the “Hearing Panel”), the scope of the Hearing Panel’s review is limited. …”see in full comparison
“Accordingly, were we to amend our Amended and Restated Articles to extend the date by which we are permitted to consummate our initial Business Combination, we would still need to consummate our initial Business Combination on or prior to February 4, 2028 in order to avoid a suspension of our securities from trading on and delisting from Nasdaq. If Nasdaq were to suspend our securities from trading and delist our securities, our securities could potentially be quoted on an over-the-counter market. …”see in full comparison
“Certain agreements related to the Initial Public Offering may be amended, or their provisions waived, without shareholder approval.”see in full comparison
“Certain of the agreements related to the Initial Public Offering to which we are a party may be amended, or their provisions waived, without shareholder approval. Such agreements include the (i) Underwriting Agreement, (ii) the Letter Agreement, (iii) the Registration Rights Agreement, (iii) the Private Placement Units Purchase Agreements and (iv) the Administrative Services Agreement. These agreements contain various provisions that our Public Shareholders might deem to be material. …”see in full comparison
Full comparison: every changed paragraph (8)
As a smaller reporting company under Rule 12b-2
of the Exchange Act, we are not required to include risk factors in this Report. However, for detailed descriptions of the risks relating
to our Company, see the section titled “Risk Factors” contained in our (i) IPO Registration Statement, (ii) 2025 Annual Report
and (iii) 2025 First Quarter Form 10-Q, 2025 Second Quarter Form 10-Q and 20252026 SecondFirst Quarter Form 10-Q. As of the date of this Report,
there have been no
material changes with respect to those risk factors, other than as set forth below.factors. Any of these previously disclosed
risk factors could
result in a significant or material adverse effect on our results of operations or financial condition. Additional
risks not presently
known to us or that we currently deem immaterial may also affect our ability to consummate an initial Business Combination.
We may disclose
changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.
We anticipate that our securities will be
suspended from trading on Nasdaq and delisted if we do not consummate our initial Business Combination by February 4, 2028. Any trading
suspension or delisting could have a material adverse effect on the trading of our securities and may adversely affect our ability to
consummate an initial Business Combination.
Our IPO Registration Statement was declared effective
by the SEC on February 4, 2025 and our securities are currently listed on the Global Market tier of Nasdaq. Pursuant to our Amended and
Restated Articles, we have until November 6, 2026 to consummate our initial Business Combination.
Under the Nasdaq Rules, a SPAC’s Nasdaq-listed
securities will be immediately suspended from trading if the SPAC does not meet the Nasdaq 36-Month Requirement, and Nasdaq will, at such
point, commence delisting procedures. Although a SPAC can request a hearing before the hearing panel of Nasdaq (the “Hearing Panel”),
the scope of the Hearing Panel’s review is limited. If a SPAC completes a Business Combination after receiving a delisting determination
by the staff of the Listing Qualifications Department of Nasdaq (a “Staff Delisting Determination”) and/or demonstrates compliance
with all applicable initial listing requirements, the combined company can apply to list its securities on Nasdaq pursuant to the normal
application review process. The Nasdaq Rules contain a list of deficiencies that would immediately result in a Staff Delisting Determination,
which includes noncompliance with the Nasdaq 36-Month Requirement.
Accordingly, were we to amend our Amended and
Restated Articles to extend the date by which we are permitted to consummate our initial Business Combination, we would still need to
consummate our initial Business Combination on or prior to February 4, 2028 in order to avoid a suspension of our securities from trading
on and delisting from Nasdaq. If Nasdaq were to suspend our securities from trading and delist our securities, our securities could potentially
be quoted on an over-the-counter market. Even if our securities are then quoted on an over-the-counter market, our Nasdaq suspension and
delisting could have significant material adverse consequences, including:
In addition, if our securities are delisted from
Nasdaq, trading in our securities, and offers and sales of our securities by us, may be subject to state securities regulation and additional
compliance costs.
Certain agreements related to the Initial
Public Offering may be amended, or their provisions waived, without shareholder approval.
Certain of the agreements related to the Initial
Public Offering to which we are a party may be amended, or their provisions waived, without shareholder approval. Such agreements include
the (i) Underwriting Agreement, (ii) the Letter Agreement, (iii) the Registration Rights Agreement, (iii) the Private Placement Units
Purchase Agreements and (iv) the Administrative Services Agreement. These agreements contain various provisions that our Public Shareholders
might deem to be material. For example, our Letter Agreement and the Underwriting Agreement contain certain lock-up provisions with respect
to the Founder Shares and other securities held by our Sponsor, officers and directors, subject to certain exceptions. Amendments or waivers
to such agreements would require the consent of the applicable parties thereto and, in certain cases, the consent of the underwriters
of the Initial Public Offering. Any such modification, such as an amendment to shorten lock-up restrictions, may benefit our Sponsor,
officers and/or directors. Any such amendments would not require approval from our shareholders, may result in the completion of our initial
Business Combination that may not otherwise have been possible, and may have an adverse effect on the value of an investment in our securities.
For example, although we would not amend lock-up provisions to permit securities held by our Sponsor to be freely sold prior to our initial
Business Combination, we may amend such provisions to permit them to be freely sold after the Business Combination earlier than they would
otherwise be permitted, which may have an adverse effect on the price of our securities.
Management's Discussion & Analysis (MD&A)
New heading “Recent Developments”
Largest changes
“Our liquidity needs through February 6, 2025 were satisfied through (i) a contribution of $25,000 from the Sponsor in exchange for the issuance of our Founder Shares and (ii) a loan pursuant to the IPO Promissory Note. Following the Initial Public Offering and the Private Placement, our liquidity needs through June 30, 2026 have been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside the Trust Account.”see in full comparison
“Our liquidity needs through March 31, 2026 have been satisfied through (i) a contribution of $25,000 from the Sponsor in exchange for the issuance of our Founder Shares, (ii) a loan pursuant to the IPO Promissory Note and (iii) the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside the Trust Account.”see in full comparison
“Furthermore, pursuant to the Letter Agreement, our Sponsor, directors and officers have agreed that: …”see in full comparison
Commencing on February 6, 2025 and until the completion of our Business Combination or liquidation, we reimburse the Sponsor $25,000 per month for office space, utilities, and secretarial and administrative support pursuant to the Administrative Services Agreement.see in full comparisonAsFor the three and six months ended June 30, 2026, we incurred and paid $75,000 and $150,000 ofMarchadministrative31,services2026fees, respectively, pursuant to the Administrative Services Agreement. For the three and six months ended June 30, 2025, we incurred and paid $75,000 and$50,000,$125,000 of administrative services fees, respectively,inpursuant tofeestheforAdministrativetheseServicesservices.Agreement.
“The Sponsor and our Company have agreed that, beginning in August 2026, the payment of fees made pursuant to the Administrative Services Agreement will be suspended. Instead, the monthly fees under the Administrative Services Agreement will be accrued and paid upon the completion of our initial Business Combination or our liquidation.”see in full comparison
Full comparison: every changed paragraph (20)
Following the closing of the Initial Public Offering
and Private Placement, an amount of $288,937,500 from the net proceeds of the Initial Public Offering and the Private Placement was initially
placed in the Trust Account located in the United States with Continental acting as trustee. Pursuant to the Trust Agreement, the Trust
Account may be invested only (i) in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company
Act with a maturity of 185 days or less, (ii) in any open-ended investment company that holds itself out as a money market fund selected
by us meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, (iii) as uninvested
cash or (iv) in an interest or non-interest bearing demand deposit accountsaccount at a U.S. chartered commercial bank with consolidated assets
of $100 billion or more selected by Continental that is reasonably satisfactory to us, until the earlier of: (x) the completion of the
Business Combination and (y) the distribution of the Trust Account, as described below.
Recent Developments
The Sponsor and our Company have agreed that, beginning in August 2026, the payment of fees made pursuant to the Administrative Services Agreement will be suspended. Instead, the monthly fees under the Administrative Services Agreement will be accrued and paid upon the completion of our initial Business Combination or our liquidation.
We have neither engaged in any operations nor
generated any revenues to date. Our only activities since July 2, 2024 (inception) through MarchJune 31,30, 2026 have been (i) organizational
activities and (ii) activities relating to (x) the Initial Public Offering and (y) identifying and evaluating prospective acquisition
candidates and activities in connection with the initial Business Combination. We will not generate any operating revenues until after
completion of our initial Business Combination. We have generated non-operating income in the form of interest income on investments held
in the Trust Account after the Initial Public Offering. We expect to incur increased expenses as a result of being a public company (for
legal, financial reporting, accounting and auditing compliance, among other things), as well as for due diligence expenses.
For the three months ended MarchJune 31,30, 2026, we had
had a net income of $2,403,751,$2,483,913, which consists of income on cash and securities held in the Trust Account of $2,636,791,$2,677,671 and bank account interest
of $1,053, offset by loss
from operations of $233,040.$194,811.
For the three months ended MarchJune 31,30, 2025, we had
had a net income of $1,601,840,$2,914,691, which consists of income on cash and securitiesinvestments held in the Trust Account of $1,792,415,$3,091,950, offset by loss
from operations
of $190,575.$177,259.
For the six months ended June 30, 2026, we had a net income of $4,887,664, which consists of income on cash and securities held in the Trust Account of $5,314,462 and bank account interest of $4,249, offset by loss from operations of $431,047.
For the six months ended June 30, 2025, we had a net income of $4,516,531, which consists of income on investments held in the Trust Account of $4,884,365, offset by loss from operations of $367,834.
Our liquidity needs through February 6, 2025 were satisfied through (i) a contribution of $25,000 from the Sponsor in exchange for the issuance of our Founder Shares and (ii) a loan pursuant to the IPO Promissory Note. Following the Initial Public Offering and the Private Placement, our liquidity needs through June 30, 2026 have been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside the Trust Account.
Following the Initial Public Offering, including
the full exercise of the Over-Allotment Option, and the Private Placement, a total of $288,937,500 was initially placed in the Trust Account. We
We incurred fees of $16,427,868 in the Initial Public Offering, consisting of $15,812,500 of cash underwriting feefee, the Deferred Underwriting
Fee of $10,062,500 and $615,368 of other
offering costs.
For the threesix months ended MarchJune 31,30, 2026, cash used
used in operating activities was $278,286.$410,363. Net income of $2,403,751$4,887,664 was affected by interest earned on cash and securities held in the Trust
Trust Account of $2,636,791.$5,314,462. Changes in operating assets and liabilities usedprovided $45,246$16,435 of cash for operating activities.
For the threesix months ended MarchJune 31,30, 2025, cash used
used in operating activities was $391,993.$590,306. Net income of $1,601,840$4,516,531 was affected by interest earned on cash and securitiesinvestments held in the
Trust Account
of $1,792,415$4,884,365 and payment of operation costs through promissorythe noteIPO Promissory Note of $48,000. Changes in operating assets and liabilities used
used $249,418$270,472 of cash for operating activities.
As of MarchJune 31,30, 2026, we had marketable securities
held in the Trust Account of $302,512,950$305,190,621 (including approximately $13,575,450$16,253,121 of interest income). We may withdraw interest from the
Trust Account to pay taxes, if any. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing
interest earned on the Trust Account (which interest shall be net of any taxes payable, and exclude the Deferred Underwriting Fee), to
complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete
our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of
the target business or businesses, make other acquisitions and pursue our growth strategies.
As of MarchJune 31,30, 2026, we had cash held outside
of the Trust Account of approximately $224,160.$92,083. We use the funds held outside the Trust Account primarily to identify and evaluate target
businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants, or similar locations
of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective
target businesses, and structure, negotiate and complete a Business Combination.
Our liquidity needs through March 31, 2026 have
been satisfied through (i) a contribution of $25,000 from the Sponsor in exchange for the issuance of our Founder Shares, (ii) a loan
pursuant to the IPO Promissory Note and (iii) the net proceeds from the consummation of the Initial Public Offering and the Private Placement
held outside the Trust Account.
In order to fund working capital deficiencies
or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their
affiliates may, but are not obligated to, loan us Working Capital Loans, as may be required. If we complete a Business Combination, we
intend to repay such Working Capital Loans. In the event that a Business Combination does not close, we may use a portion of the working
capital held outside the Trust Account to repay such Working Capital Loans, but no proceeds from our Trust Account will be used for such
repayment. Up to $1,500,000 of such Working Capital Loans may be converted into units of the post-Business Combination entity at a price
of $10.00 per unit. TheSuch units (and underlying securities) would be identical to the Private Placement Units (and underlying securities).
As of MarchJune 31,30, 2026 and December 31, 2025, we did not have any borrowings under any Working Capital Loans.
Commencing on February 6, 2025 and until the completion
of our Business Combination or liquidation, we reimburse the Sponsor $25,000 per month for office space, utilities, and secretarial and
administrative support pursuant to the Administrative Services Agreement. AsFor the three and six months ended June 30, 2026, we incurred
and paid $75,000 and $150,000 of Marchadministrative 31,services 2026fees, respectively, pursuant to the Administrative Services Agreement. For the
three and six months ended June 30, 2025, we incurred and paid $75,000 and $50,000,
$125,000 of administrative services fees, respectively, inpursuant
to feesthe forAdministrative theseServices services.Agreement.
See “Recent Developments” above for additional information regarding the Administrative Services Agreement.
Furthermore, pursuant to the Letter Agreement, our Sponsor, directors and officers have agreed that: (x) the Founder Shares shall be subject to transfer restrictions of the earlier of (i) one year after the completion of our initial Business Combination or earlier if, subsequent to our initial Business Combination, the closing price of the Class A Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 30 days after our initial Business Combination and (ii) the date following the completion of our initial Business Combination on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our shareholders having the right to exchange their Class A Ordinary Shares for cash, securities or other property, (y) the Private Placement Units (including their underlying securities) shall be subject to transfer restriction until 30 days after the completion of our initial Business Combination and (z) any Units, Rights, Ordinary Shares or any other securities convertible into, or exercisable or exchangeable for, any Units, Ordinary Shares, Founder Shares or Rights were subject to transfer restrictions for 180 days following the filing of the prospectus for the Initial Public Offering.
The preparation of the unaudited condensed financial
statements and notes thereto included in this Report under Item 1. “Financial Statements” in conformity with GAAP requires
Management to make estimates and assumptions that affect the reported amounts of assets and liabilities, income and expenses, and the
disclosure of contingent assets and liabilities, in our unaudited condensed financial statements. These accounting estimates require the
use of assumptions about matters, some of which are highly uncertain at the time of estimation. Management bases its estimates on historical
experience and on various other assumptions it believes to be reasonable under the circumstances, the results of which form the basis
for making judgments, and we evaluate these estimates on an ongoing basis. To the extent actual experience differs from the assumptions
used, our unaudited condensed financial statements and notes thereto included in this Report under Item 1. “Financial Statements”
could be materially affected. We believe that the following accounting policies involve a higher degree of judgment and complexity. As
of MarchJune 31,30, 2026, we did not have any critical accounting estimates to be disclosed.
KFII insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding KFII (13F)
None of the 59 investors we track reported a position in their latest 13F.